These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8016661)

  • 21. Hepatic denervation alters first-phase urinary sodium excretion in dogs with cirrhosis.
    Levy M; Wexler MJ
    Am J Physiol; 1987 Oct; 253(4 Pt 2):F664-71. PubMed ID: 3661718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites.
    Arroyo V; Clària J; Saló J; Jiménez W
    Semin Liver Dis; 1994 Feb; 14(1):44-58. PubMed ID: 8016662
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis.
    Wong F; Liu P; Lilly L; Bomzon A; Blendis L
    Clin Sci (Lond); 1999 Sep; 97(3):259-67. PubMed ID: 10464050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ursodeoxycholic acid on systemic, renal and forearm haemodynamics and sodium homoeostasis in cirrhotic patients with refractory ascites.
    Wong F; Bomzon A; Allard J; Liu P; Blendis L
    Clin Sci (Lond); 1999 May; 96(5):467-74. PubMed ID: 10209078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal sodium retention in preascitic cirrhosis: expanding knowledge, enduring uncertainties.
    Bernardi M
    Hepatology; 2002 Jun; 35(6):1544-7. PubMed ID: 12029644
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies of renin and aldosterone in cirrhotic patients with ascites.
    Rosoff L; Zia P; Reynolds T; Horton R
    Gastroenterology; 1975 Sep; 69(3):698-705. PubMed ID: 1158087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The renin-angiotensin-aldosterone system in human hepatic cirrhosis.
    Bernardi M; Gasbarrini G
    Isr J Med Sci; 1986 Feb; 22(2):70-7. PubMed ID: 3512474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac involvement in liver cirrhosis.
    Gatta A; Merkel C; Sacerdoti D; Angeli P
    Ann Ital Med Int; 1993; 8(4):244-7. PubMed ID: 8161481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of aldactone on potassium storage in patients with ascitic cirrhosis].
    Lévy VG; Lassale B; Del Corso A; Caroli J
    Ann Med Interne (Paris); 1970 Feb; 121(2):183-90. PubMed ID: 5491199
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of chronic administration of sildenafil on sodium retention and on the hemodynamic complications associated with liver cirrhosis in the rat.
    Ghali-Ghoul R; Tahseldar-Roumieh R; Sabra R
    Eur J Pharmacol; 2007 Oct; 572(1):49-56. PubMed ID: 17610866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats: evidence for a role of nitric oxide in the pathogenesis of arterial vasodilation in cirrhosis.
    Niederberger M; Ginès P; Tsai P; Martin PY; Morris K; Weigert A; McMurtry I; Schrier RW
    Hepatology; 1995 Jun; 21(6):1625-31. PubMed ID: 7768508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiology of ascites formation in cirrhosis of the liver.
    Gerbes AL
    Hepatogastroenterology; 1991 Oct; 38(5):360-4. PubMed ID: 1765351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ascites in liver diseases.
    Gentilini P; Laffi G
    Ann Ital Med Int; 1991; 6(1 Pt 2):148-55. PubMed ID: 1742150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Disorders of regulation of the stability of the intravascular fluid volume in patients with liver cirrhosis].
    Gapon LI
    Ter Arkh; 1987; 59(2):100-4. PubMed ID: 3576460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of atrial natriuretic factor on renal excretion of sodium in patients with liver cirrhosis].
    Moreau R; Lebrec D
    Gastroenterol Clin Biol; 1994; 18(6-7):568-73. PubMed ID: 7875416
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of atrial natriuretic peptide on arterial pressure and renal function in cirrhotic rats with ascites.
    López C; Jiménez W; Arroyo V; Gaya J; Rivera F; Rodés J
    Rev Esp Fisiol; 1988 Sep; 44(3):265-72. PubMed ID: 2976517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of neuropeptide Y on hemodynamics and sodium secretion in cirrhotic rats with portal hypertension].
    Zhou J; Wang T; Tang W; Liang K
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):147. PubMed ID: 11983141
    [No Abstract]   [Full Text] [Related]  

  • 38. [Function test of renal excretion of water and sodium after water loading in liver cirrhosis].
    Giudici Cipriani A; Richeri F; Falchero M; Colombo P; Bertolazzi R; Folco U; Marenco G
    Minerva Med; 1983 Jun; 74(27):1629-34. PubMed ID: 6856172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal relationships between urinary salt retention and altered systemic hemodynamics in dogs with experimental cirrhosis.
    Levy M; Allotey JB
    J Lab Clin Med; 1978 Oct; 92(4):560-9. PubMed ID: 712196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
    Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.